3D cell culture is used to facilitate the proliferation of cells in an artificial environment that mimics the natural 3D in vivo conditions. 3D cell culture can be achieved using scaffold-free or scaffold-based 3D cell cultures that efficiently permit the study of living cells in a tissue or organ. The latest report of the company tracks and forecasts the growth trends of the global 3D cell culture market from 2013 to 2028. This report projects that the global value of 3D cell culture will reach above US$ 1,990.3 Mn till 2028, growing at a 9.8% CAGR. This increase is predicted to be driven by the increasing focus on oncological research and regenerative medicine, lower drug delivery costs, and the increasing demand for bio-pharmaceuticals over the forecast period.
The 3D cell culture market is divided into scaffold-free 3D cell culture and scaffold-based 3D cell culture. Owing to the higher adoption of scaffold-based 3D cell culture, this segment generates maximum revenue in the 3D cell culture market. However, advances in 3D cell culture such as gravity-enforced spheroid formation, tumor spheroid formation, and elimination of the potential risk of scaffold interference and contamination are anticipated to create a higher demand for scaffold-free 3D cell culture. As a result, the revenue share of the scaffold-free 3D cell culture is projected to grow with a high CAGR over the forecast period. Scaffold-based 3D cell culture contributed the maximum share, in terms of revenue, in 2018 and is expected to continue this trend over the forecast years. Scaffold-based 3D cell culture segment is sub-segmented into hydrogel-based scaffolds and polymeric hard material-based scaffolds. The polymeric hard material based sub-segment is pegged to reach US$ 895.0 Mn by 2028 owing to the better facilitation for cell-cell interaction and respiration by the product.
The 3D cell culture products find application in drug discovery, stem cell technology, cancer research, tissue regeneration & regenerative medicines, and others. Cancer research is projected to continue to generate maximum revenue share over the forecast period in the global 3D cell culture market because of the increasing R&D expenditure coupled with government initiatives to accelerate the oncology research. The constantly growing awareness regarding the advantages of stem cell technology and tissue regeneration & regenerative medicines is anticipated to fuel the 3D cell culture market. Utilization of 3D cell culture for drug development saves drug discovery expenditure, shortens the process, and can be potentially substituted for animal testing in the pre-clinical testing phase. These benefits create a humongous demand for 3D cell culture for drug development. Therefore, the market is expected to grow with a high CAGR of 10.5% over the forecast period.
3D cell culture is majorly adopted by biotechnology and pharmaceutical industries owing to the higher expenditure and increasing demand for 3D cell culture. The increasing number of biotechnology and pharmaceutical industries is anticipated to share above 45% of the market, in terms of revenue, in 2028. Due to the limited applications of 3D cell culture in hospital laboratories, the segment is expected to witness stagnant growth in revenue share over the forecast period. Academic research institutes are expected to depict steady growth owing to the increasing demand for the technologically-advanced cell culture products and increasing government funding for academic research. Slow growth is estimated for contract research organizations, representing incremental opportunities of US$ 196.6 Mn over the forecast period.
North America is calculated to be the most dominant region in the global 3D cell culture market owing to the higher R&D expenditure and the growing demand for 3D cell culture by the end users. Moreover, the increasing number of biotechnology industries and manufacturers in the region contributes to the maximum revenue share by North America in the global 3D cell culture market over the forecast period. The APEJ region is forecasted to grow with high CAGR and create a significant market share, in terms of revenue, in the global 3D cell culture market. The increasing expenditure on cancer and stem cell research in APEJ is estimated to boost the demand for 3D cell culture over the forecast period. Western Europe 3D cell culture market is estimated to be a lucrative region in the 3D cell culture market. MEA and Latin America 3D cell culture markets are expected to be the least lucrative regions and represent minimum incremental opportunity over the forecast period owing to lower R&D expenditure and less product penetration.
The company has segmented the global 3D cell culture market into product type, application, end user, and region. In terms of revenue, the scaffold-based 3D cell culture segment in product type will hold a significant share over the forecast period. On the contrary, the others segment in the application market will exhibit limited investment opportunities, in terms of revenue, through 2028.
The company’s report tracks some of the key companies operating in the 3D cell culture market, such as, Merck KGaA, Lonza, Thermo Fisher Scientific, Lena Biosciences, 3D Biotek LLC, Nanofiber Solutions, Inc., REPROCELL, MicroTissues, Inc., Corning Incorporated, Becton, Dickinson and Company, Synthecon, Inc. and Greiner Group AG.
A sample of this report is available upon request @https://www.futuremarketinsights.com/reports/sample/rep-gb-2843